Acute lupus myocarditis: clinical features and outcome of an oriental case series

Symptomatic myocarditis in systemic lupus erythematosus (SLE) is uncommon. We describe the clinical characteristics, management and outcomes of 11 SLE patients without any atherosclerotic risk factors, who presented with acute lupus myocarditis (ALM). All patients were female, 46% Chinese with mean...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lupus 2005, Vol.14 (10), p.827-831
Hauptverfasser: Law, W G, Thong, B Y, Lian, T Y, Kong, K O, Chng, H H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 831
container_issue 10
container_start_page 827
container_title Lupus
container_volume 14
creator Law, W G
Thong, B Y
Lian, T Y
Kong, K O
Chng, H H
description Symptomatic myocarditis in systemic lupus erythematosus (SLE) is uncommon. We describe the clinical characteristics, management and outcomes of 11 SLE patients without any atherosclerotic risk factors, who presented with acute lupus myocarditis (ALM). All patients were female, 46% Chinese with mean age of 27 < 10 years at diagnosis of SLE. ALM was one of the initial manifestations of SLE in eight (73%) patients. The median duration from onset ALM to initiation of treatment was two weeks (range: 0.3-8). All had clinical feature of left ventricle dysfunction. The most common electrocardiographic feature was nonspecific ST/T wave changes (91%). Common echocardiographic findings included segmental wall motion abnormalities (81%) and decreased left ventricular ejection fraction (81%). Median SLE disease activity index at presentation was 16 (range: 4-30). All patients received high dose corticosteroids and 64% received intravenous pulse cyclophosphamide. There were two deaths (18%) from infections. The remaining nine survivors had no recurrence of ALM nor suffer any SLE-related damage (median SLICC damage score of 0), up to a median follow-up of four years (range: 2.5-10.1). Repeat echocardiography after six months or later showed normal LVEF in eight patients (89%). Early immunosuppressive therapy in ALM, with high dose corticosteroids and pulse intravenous cyclophosphamide, results in good cardiac outcome.
doi_str_mv 10.1191/0961203305lu2228oa
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17413886</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1191_0961203305lu2228oa</sage_id><sourcerecordid>17413886</sourcerecordid><originalsourceid>FETCH-LOGICAL-c314t-82cbb179eae529f5a63d816e123303df25c374bad922dbbe862fa040922f036b3</originalsourceid><addsrcrecordid>eNp9kE9LxDAQxYMo7rr6BTxI8OCtbiZp09bbsvgPFkTQc0nTiXRpmzVpDvvtzbILCwqehsf85s3MI-Qa2D1ACXNWSuBMCJZ1gXNeWHVCppDmeRI7_JRMd0CyIybkwvs1Y0xAKc_JBKRgXObFlLwvdBiRdmETPO23VivXtGPrH6ju2qHVqqMG1RgceqqGhtowatsjtSZKal2LwxgZrTxSj1H6S3JmVOfx6lBn5PPp8WP5kqzenl-Xi1WiBaRjUnBd15CXqDDjpcmUFE0BEoHHh0RjeKZFntaqKTlv6hoLyY1iKYvSMCFrMSN3e9-Ns98B_Vj1rdfYdWpAG3wFeQqiKGQEb3-BaxvcEG-rYmpSlDmICPE9pJ313qGpNq7tldtWwKpd2tXftOPQzcE51D02x5FDvBGY7wGvvvC49h_LHz60iQo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>222639713</pqid></control><display><type>article</type><title>Acute lupus myocarditis: clinical features and outcome of an oriental case series</title><source>Access via SAGE</source><source>MEDLINE</source><creator>Law, W G ; Thong, B Y ; Lian, T Y ; Kong, K O ; Chng, H H</creator><creatorcontrib>Law, W G ; Thong, B Y ; Lian, T Y ; Kong, K O ; Chng, H H</creatorcontrib><description>Symptomatic myocarditis in systemic lupus erythematosus (SLE) is uncommon. We describe the clinical characteristics, management and outcomes of 11 SLE patients without any atherosclerotic risk factors, who presented with acute lupus myocarditis (ALM). All patients were female, 46% Chinese with mean age of 27 &lt; 10 years at diagnosis of SLE. ALM was one of the initial manifestations of SLE in eight (73%) patients. The median duration from onset ALM to initiation of treatment was two weeks (range: 0.3-8). All had clinical feature of left ventricle dysfunction. The most common electrocardiographic feature was nonspecific ST/T wave changes (91%). Common echocardiographic findings included segmental wall motion abnormalities (81%) and decreased left ventricular ejection fraction (81%). Median SLE disease activity index at presentation was 16 (range: 4-30). All patients received high dose corticosteroids and 64% received intravenous pulse cyclophosphamide. There were two deaths (18%) from infections. The remaining nine survivors had no recurrence of ALM nor suffer any SLE-related damage (median SLICC damage score of 0), up to a median follow-up of four years (range: 2.5-10.1). Repeat echocardiography after six months or later showed normal LVEF in eight patients (89%). Early immunosuppressive therapy in ALM, with high dose corticosteroids and pulse intravenous cyclophosphamide, results in good cardiac outcome.</description><identifier>ISSN: 0961-2033</identifier><identifier>EISSN: 1477-0962</identifier><identifier>DOI: 10.1191/0961203305lu2228oa</identifier><identifier>PMID: 16302678</identifier><language>eng</language><publisher>Thousand Oaks, CA: SAGE Publications</publisher><subject>Adult ; Atherosclerosis ; Cardiovascular disease ; Coronary vessels ; Cyclophosphamide - therapeutic use ; Dose-Response Relationship, Drug ; Drug Therapy, Combination ; Echocardiography ; Ejection fraction ; Female ; Glucocorticoids - therapeutic use ; Heart ; Humans ; Immunology ; Injections, Intravenous ; Lupus ; Lupus Erythematosus, Systemic - drug therapy ; Lupus Erythematosus, Systemic - pathology ; Myocarditis ; Myocarditis - drug therapy ; Myocarditis - pathology ; Patients ; Pulmonary arteries ; Retrospective Studies ; Rheumatology ; Severity of Illness Index ; Steroids ; Treatment Outcome ; Vein &amp; artery diseases ; Ventricular Dysfunction, Left - drug therapy ; Ventricular Dysfunction, Left - pathology</subject><ispartof>Lupus, 2005, Vol.14 (10), p.827-831</ispartof><rights>2005 Arnold</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c314t-82cbb179eae529f5a63d816e123303df25c374bad922dbbe862fa040922f036b3</citedby><cites>FETCH-LOGICAL-c314t-82cbb179eae529f5a63d816e123303df25c374bad922dbbe862fa040922f036b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1191/0961203305lu2228oa$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1191/0961203305lu2228oa$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,4024,21819,27923,27924,27925,43621,43622</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16302678$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Law, W G</creatorcontrib><creatorcontrib>Thong, B Y</creatorcontrib><creatorcontrib>Lian, T Y</creatorcontrib><creatorcontrib>Kong, K O</creatorcontrib><creatorcontrib>Chng, H H</creatorcontrib><title>Acute lupus myocarditis: clinical features and outcome of an oriental case series</title><title>Lupus</title><addtitle>Lupus</addtitle><description>Symptomatic myocarditis in systemic lupus erythematosus (SLE) is uncommon. We describe the clinical characteristics, management and outcomes of 11 SLE patients without any atherosclerotic risk factors, who presented with acute lupus myocarditis (ALM). All patients were female, 46% Chinese with mean age of 27 &lt; 10 years at diagnosis of SLE. ALM was one of the initial manifestations of SLE in eight (73%) patients. The median duration from onset ALM to initiation of treatment was two weeks (range: 0.3-8). All had clinical feature of left ventricle dysfunction. The most common electrocardiographic feature was nonspecific ST/T wave changes (91%). Common echocardiographic findings included segmental wall motion abnormalities (81%) and decreased left ventricular ejection fraction (81%). Median SLE disease activity index at presentation was 16 (range: 4-30). All patients received high dose corticosteroids and 64% received intravenous pulse cyclophosphamide. There were two deaths (18%) from infections. The remaining nine survivors had no recurrence of ALM nor suffer any SLE-related damage (median SLICC damage score of 0), up to a median follow-up of four years (range: 2.5-10.1). Repeat echocardiography after six months or later showed normal LVEF in eight patients (89%). Early immunosuppressive therapy in ALM, with high dose corticosteroids and pulse intravenous cyclophosphamide, results in good cardiac outcome.</description><subject>Adult</subject><subject>Atherosclerosis</subject><subject>Cardiovascular disease</subject><subject>Coronary vessels</subject><subject>Cyclophosphamide - therapeutic use</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Therapy, Combination</subject><subject>Echocardiography</subject><subject>Ejection fraction</subject><subject>Female</subject><subject>Glucocorticoids - therapeutic use</subject><subject>Heart</subject><subject>Humans</subject><subject>Immunology</subject><subject>Injections, Intravenous</subject><subject>Lupus</subject><subject>Lupus Erythematosus, Systemic - drug therapy</subject><subject>Lupus Erythematosus, Systemic - pathology</subject><subject>Myocarditis</subject><subject>Myocarditis - drug therapy</subject><subject>Myocarditis - pathology</subject><subject>Patients</subject><subject>Pulmonary arteries</subject><subject>Retrospective Studies</subject><subject>Rheumatology</subject><subject>Severity of Illness Index</subject><subject>Steroids</subject><subject>Treatment Outcome</subject><subject>Vein &amp; artery diseases</subject><subject>Ventricular Dysfunction, Left - drug therapy</subject><subject>Ventricular Dysfunction, Left - pathology</subject><issn>0961-2033</issn><issn>1477-0962</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kE9LxDAQxYMo7rr6BTxI8OCtbiZp09bbsvgPFkTQc0nTiXRpmzVpDvvtzbILCwqehsf85s3MI-Qa2D1ACXNWSuBMCJZ1gXNeWHVCppDmeRI7_JRMd0CyIybkwvs1Y0xAKc_JBKRgXObFlLwvdBiRdmETPO23VivXtGPrH6ju2qHVqqMG1RgceqqGhtowatsjtSZKal2LwxgZrTxSj1H6S3JmVOfx6lBn5PPp8WP5kqzenl-Xi1WiBaRjUnBd15CXqDDjpcmUFE0BEoHHh0RjeKZFntaqKTlv6hoLyY1iKYvSMCFrMSN3e9-Ns98B_Vj1rdfYdWpAG3wFeQqiKGQEb3-BaxvcEG-rYmpSlDmICPE9pJ313qGpNq7tldtWwKpd2tXftOPQzcE51D02x5FDvBGY7wGvvvC49h_LHz60iQo</recordid><startdate>2005</startdate><enddate>2005</enddate><creator>Law, W G</creator><creator>Thong, B Y</creator><creator>Lian, T Y</creator><creator>Kong, K O</creator><creator>Chng, H H</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>2005</creationdate><title>Acute lupus myocarditis: clinical features and outcome of an oriental case series</title><author>Law, W G ; Thong, B Y ; Lian, T Y ; Kong, K O ; Chng, H H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c314t-82cbb179eae529f5a63d816e123303df25c374bad922dbbe862fa040922f036b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Atherosclerosis</topic><topic>Cardiovascular disease</topic><topic>Coronary vessels</topic><topic>Cyclophosphamide - therapeutic use</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Therapy, Combination</topic><topic>Echocardiography</topic><topic>Ejection fraction</topic><topic>Female</topic><topic>Glucocorticoids - therapeutic use</topic><topic>Heart</topic><topic>Humans</topic><topic>Immunology</topic><topic>Injections, Intravenous</topic><topic>Lupus</topic><topic>Lupus Erythematosus, Systemic - drug therapy</topic><topic>Lupus Erythematosus, Systemic - pathology</topic><topic>Myocarditis</topic><topic>Myocarditis - drug therapy</topic><topic>Myocarditis - pathology</topic><topic>Patients</topic><topic>Pulmonary arteries</topic><topic>Retrospective Studies</topic><topic>Rheumatology</topic><topic>Severity of Illness Index</topic><topic>Steroids</topic><topic>Treatment Outcome</topic><topic>Vein &amp; artery diseases</topic><topic>Ventricular Dysfunction, Left - drug therapy</topic><topic>Ventricular Dysfunction, Left - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Law, W G</creatorcontrib><creatorcontrib>Thong, B Y</creatorcontrib><creatorcontrib>Lian, T Y</creatorcontrib><creatorcontrib>Kong, K O</creatorcontrib><creatorcontrib>Chng, H H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Lupus</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Law, W G</au><au>Thong, B Y</au><au>Lian, T Y</au><au>Kong, K O</au><au>Chng, H H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acute lupus myocarditis: clinical features and outcome of an oriental case series</atitle><jtitle>Lupus</jtitle><addtitle>Lupus</addtitle><date>2005</date><risdate>2005</risdate><volume>14</volume><issue>10</issue><spage>827</spage><epage>831</epage><pages>827-831</pages><issn>0961-2033</issn><eissn>1477-0962</eissn><abstract>Symptomatic myocarditis in systemic lupus erythematosus (SLE) is uncommon. We describe the clinical characteristics, management and outcomes of 11 SLE patients without any atherosclerotic risk factors, who presented with acute lupus myocarditis (ALM). All patients were female, 46% Chinese with mean age of 27 &lt; 10 years at diagnosis of SLE. ALM was one of the initial manifestations of SLE in eight (73%) patients. The median duration from onset ALM to initiation of treatment was two weeks (range: 0.3-8). All had clinical feature of left ventricle dysfunction. The most common electrocardiographic feature was nonspecific ST/T wave changes (91%). Common echocardiographic findings included segmental wall motion abnormalities (81%) and decreased left ventricular ejection fraction (81%). Median SLE disease activity index at presentation was 16 (range: 4-30). All patients received high dose corticosteroids and 64% received intravenous pulse cyclophosphamide. There were two deaths (18%) from infections. The remaining nine survivors had no recurrence of ALM nor suffer any SLE-related damage (median SLICC damage score of 0), up to a median follow-up of four years (range: 2.5-10.1). Repeat echocardiography after six months or later showed normal LVEF in eight patients (89%). Early immunosuppressive therapy in ALM, with high dose corticosteroids and pulse intravenous cyclophosphamide, results in good cardiac outcome.</abstract><cop>Thousand Oaks, CA</cop><pub>SAGE Publications</pub><pmid>16302678</pmid><doi>10.1191/0961203305lu2228oa</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0961-2033
ispartof Lupus, 2005, Vol.14 (10), p.827-831
issn 0961-2033
1477-0962
language eng
recordid cdi_proquest_miscellaneous_17413886
source Access via SAGE; MEDLINE
subjects Adult
Atherosclerosis
Cardiovascular disease
Coronary vessels
Cyclophosphamide - therapeutic use
Dose-Response Relationship, Drug
Drug Therapy, Combination
Echocardiography
Ejection fraction
Female
Glucocorticoids - therapeutic use
Heart
Humans
Immunology
Injections, Intravenous
Lupus
Lupus Erythematosus, Systemic - drug therapy
Lupus Erythematosus, Systemic - pathology
Myocarditis
Myocarditis - drug therapy
Myocarditis - pathology
Patients
Pulmonary arteries
Retrospective Studies
Rheumatology
Severity of Illness Index
Steroids
Treatment Outcome
Vein & artery diseases
Ventricular Dysfunction, Left - drug therapy
Ventricular Dysfunction, Left - pathology
title Acute lupus myocarditis: clinical features and outcome of an oriental case series
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T10%3A32%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acute%20lupus%20myocarditis:%20clinical%20features%20and%20outcome%20of%20an%20oriental%20case%20series&rft.jtitle=Lupus&rft.au=Law,%20W%20G&rft.date=2005&rft.volume=14&rft.issue=10&rft.spage=827&rft.epage=831&rft.pages=827-831&rft.issn=0961-2033&rft.eissn=1477-0962&rft_id=info:doi/10.1191/0961203305lu2228oa&rft_dat=%3Cproquest_cross%3E17413886%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=222639713&rft_id=info:pmid/16302678&rft_sage_id=10.1191_0961203305lu2228oa&rfr_iscdi=true